Filing Details
- Accession Number:
- 0001640334-19-000942
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-05-20 20:37:12
- Reporting Period:
- 2019-05-02
- Accepted Time:
- 2019-05-20 20:37:12
- Original Submission Date:
- 2019-05-06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711754 | Inmune Bio Inc. | INMB | Biological Products, (No Disgnostic Substances) (2836) | 475205835 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1767280 | Joseph Raymond Tesi | C/O Inmune Bio Inc. 1224 Prospect Street, Suite 150 La Jolla CA 92037 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-02 | 11,100 | $10.75 | 1,526,933 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 11,100 shares of the Issuer's common stock acquired by the Reporting Person in connection with a private placement effected as of May 2, 2019.
- On May 16, 2019, the Issuer and Dr. Tesi entered into an Amendment to the Securities Purchase Agreement, pursuant to which the definition of "purchase price" in the Securities Purchase Agreement, dated May 2, 2019, entered into by and between the Issuer and Mr. Tesi was amended to be $10.75 per share (from $9.00). On May 16, 2019, Dr. Tesi paid the Issuer $19,425, representing the additional amount of the purchase price.
Billionaire Hedge Funds
